Evidence map›Paper›PMID 36112688›Full record

ReviewScience advances2022

Brain lipidomics: From functional landscape to clinical significance.

Jong Hyuk Yoon, Youngsuk Seo, Yeon Suk Jo, Seulah Lee, Eunji Cho, Amaury Cazenave-Gassiot, Yong-Seung Shin, Myeong Hee Moon, Hyun Joo An, Markus R Wenk and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 2 pooled it
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 2 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Lipid metabolism in moyamoya disease: Emerging evidence, vascular remodeling, and therapeutic implications.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The Emerging Parkinson's Disease Oxylipin-Ome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  17. A lifespan staging model of basal forebrain cholinergic vulnerability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  18. Review
  19. Article
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Jong Hyuk YoonNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID 0000-0002-4090-3832
Youngsuk SeoNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID 0000-0002-8934-3290
Yeon Suk JoNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Seulah LeeNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID 0000-0003-1019-5991
Eunji ChoNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID 0000-0002-9589-3643
Amaury Cazenave-GassiotDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore.ORCID 0000-0002-3050-634X
Yong-Seung ShinLaboratory Solutions Sales, Agilent Technologies Korea Ltd., Seoul, 06621, Republic of Korea.ORCID 0000-0002-2738-6201
Myeong Hee MoonDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.ORCID 0000-0002-5454-2601
Hyun Joo AnGraduate School of Analytical Science and Technology, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0000-0001-5847-7483
Markus R WenkDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore.ORCID 0000-0001-5447-7881
Pann-Ghill SuhKorea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID 0000-0002-9811-756X
Korea Brain Research Institute · KRNational University of Singapore · SGAgilent Technologies (United States) · USChungnam National University · KRDaegu Gyeongbuk Institute of Science and Technology · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipids are crucial components of cellular function owing to their role in membrane formation, intercellular signaling, energy storage, and homeostasis maintenance. In the brain, lipid dysregulations have been associated with the etiology and progression of neurodegeneration and other neurological pathologies. Hence, brain lipids are emerging as important potential targets for the early diagnosis and prognosis of neurological diseases. This review aims to highlight the significance and usefulness of lipidomics in diagnosing and treating brain diseases. We explored lipid alterations associated with brain diseases, paying attention to organ-specific characteristics and the functions of brain lipids. As the recent advances in brain lipidomics would have been impossible without advances in analytical techniques, we provide up-to-date information on mass spectrometric approaches and integrative analysis with other omic approaches. Last, we present the potential applications of lipidomics combined with artificial intelligence techniques and interdisciplinary collaborative research for treating brain diseases with clinical heterogeneities.

Indexed as

Brain DiseasesLipidomicsArtificial IntelligenceBrainHumansLipid MetabolismLipidsLipids

Identifiers

PMID36112688
PMCPMC9481132
OpenAlexW4296163350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.